Myxoid Liposarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-02-03
Clinical Trial Update: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma [Phase 1]
Phase 1 trial of NY-ESO-1–specific T cells after cyclophosphamide for advanced synovial sarcoma or myxoid liposarcoma has been withdrawn.